Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP505350.RAgX4AT2tYnzC61zskSt1FNrFXBR7_Lhrlnx-0SiuVQ0s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP505350.RAgX4AT2tYnzC61zskSt1FNrFXBR7_Lhrlnx-0SiuVQ0s130_assertion type Assertion NP505350.RAgX4AT2tYnzC61zskSt1FNrFXBR7_Lhrlnx-0SiuVQ0s130_head.
- NP505350.RAgX4AT2tYnzC61zskSt1FNrFXBR7_Lhrlnx-0SiuVQ0s130_assertion description "[In multivariate analyses, we found a 30% [95% confidence interval (CI) = 0.8-1.9] elevated risk of breast cancer associated with the NAT1*10 allele and a nearly 4-fold (95% CI = 1.5-10.5) elevated risk associated with the NAT1*11 allele.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505350.RAgX4AT2tYnzC61zskSt1FNrFXBR7_Lhrlnx-0SiuVQ0s130_provenance.
- NP505350.RAgX4AT2tYnzC61zskSt1FNrFXBR7_Lhrlnx-0SiuVQ0s130_assertion evidence source_evidence_literature NP505350.RAgX4AT2tYnzC61zskSt1FNrFXBR7_Lhrlnx-0SiuVQ0s130_provenance.
- NP505350.RAgX4AT2tYnzC61zskSt1FNrFXBR7_Lhrlnx-0SiuVQ0s130_assertion SIO_000772 10090301 NP505350.RAgX4AT2tYnzC61zskSt1FNrFXBR7_Lhrlnx-0SiuVQ0s130_provenance.
- NP505350.RAgX4AT2tYnzC61zskSt1FNrFXBR7_Lhrlnx-0SiuVQ0s130_assertion wasDerivedFrom befree-20140225 NP505350.RAgX4AT2tYnzC61zskSt1FNrFXBR7_Lhrlnx-0SiuVQ0s130_provenance.
- NP505350.RAgX4AT2tYnzC61zskSt1FNrFXBR7_Lhrlnx-0SiuVQ0s130_assertion wasGeneratedBy ECO_0000203 NP505350.RAgX4AT2tYnzC61zskSt1FNrFXBR7_Lhrlnx-0SiuVQ0s130_provenance.